Reviva Pharmaceuticals stock is at significant support. Why did RVPH hit a new low?Reviva To Sell More Than 6 Million SharesAccording to an SEC filing from Wednesday, Reviva will sell 6,666,667 common shares priced at $1.50 each, a move that will raise more than $10 million for the company. The company will use the money to fund research and development activities, including its planned RECOVER-2 Phase 3 trial for brilaroxazine in schizophrenia, and for working capital and other general corporate purposes.T ...